Document is current
Any future updates will be listed below
-
Authors
Yang, Li
Liu, Jingfang
Zhang, Jiejie
Shao, Feng
Jin, Yanlu
Xing, Jie
Zhou, Heran
Yu, Aijun
-
Funding
Funding for this research was provided by:
Chinese Medicine Research Program of Zhejiang province (2022ZQ018)
National Natural Science Foundation of China (82274266)
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 10 July 2024
First Online: 5 August 2024
Declarations
:
: Research involving human participants was approved by the Institutional Review Board of the Zhejiang Cancer Hospital (approval no. IRB-2022-781, 2022-12-27). The informed consent was signed by each participant. All procedures on animals were approved by the Laboratory Animal Management and Ethics Committee of Zhejiang Ying Yang Pharmaceutical R&D Center (approval no. ZJEY-20230220-01, 2023-2-20).
: All written informed consent was obtained from all participants.
: The authors declare no competing interests.
